Patents Assigned to Applies Molecular Transport Inc.
  • Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
    Patent number: 10624957
    Abstract: The present disclosure relates to pharmaceutical compositions comprising a non-naturally occurring fusion molecule and one or more pharmaceutically acceptable carriers, formulated for oral delivery to a subject, and designed to provide for improved, effective therapies for treatment of, e.g., inflammatory diseases, autoimmune diseases, cancer, metabolic disorders, and growth deficiency disorders.
    Type: Grant
    Filed: December 3, 2018
    Date of Patent: April 21, 2020
    Assignee: Applies Molecular Transport Inc.
    Inventors: Randall J. Mrsny, Tahir Mahmood